BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 34105518)

  • 1. Morphology Matters: A Critical Reappraisal of the Clinical Relevance of Morphologic Criteria From the 2019 WHO Classification in a Large Colorectal Cancer Cohort Comprising 1004 Cases.
    Jesinghaus M; Schmitt M; Lang C; Reiser M; Scheiter A; Konukiewitz B; Steiger K; Silva M; Tschurtschenthaler M; Lange S; Foersch S; Becker KF; Saur D; Friess H; Halfter K; Engel J; Boxberg M; Pfarr N; Wilhelm D; Weichert W
    Am J Surg Pathol; 2021 Jul; 45(7):969-978. PubMed ID: 34105518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The presence of poorly differentiated clusters predicts survival in stage II colorectal cancer.
    Ammendola S; Turri G; Marconi I; Burato G; Pecori S; Tomezzoli A; Conti C; Pedrazzani C; Barresi V
    Virchows Arch; 2021 Feb; 478(2):241-248. PubMed ID: 32577812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathologic impacts of poorly differentiated cluster-based grading system in colorectal carcinoma.
    Kim JW; Shin MK; Kim BC
    J Korean Med Sci; 2015 Jan; 30(1):16-23. PubMed ID: 25552879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Budding, tumor-infiltrating lymphocytes, gland formation: scoring leads to new prognostic groups in World Health Organization low-grade colorectal cancer with impact on survival.
    Lang-Schwarz C; Melcher B; Haumaier F; Schneider-Fuchs A; Lang-Schwarz K; Krugmann J; Vieth M; Sterlacci W
    Hum Pathol; 2019 Jul; 89():81-89. PubMed ID: 31054898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor Budding and PDC Grade Are Stage Independent Predictors of Clinical Outcome in Mismatch Repair Deficient Colorectal Cancer.
    Ryan É; Khaw YL; Creavin B; Geraghty R; Ryan EJ; Gibbons D; Hanly A; Martin ST; O'Connell PR; Winter DC; Sheahan K
    Am J Surg Pathol; 2018 Jan; 42(1):60-68. PubMed ID: 29112018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic and predictive values of tumour budding in stage IV colorectal cancer.
    Nagata K; Shinto E; Yamadera M; Shiraishi T; Kajiwara Y; Okamoto K; Mochizuki S; Hase K; Kishi Y; Ueno H
    BJS Open; 2020 Aug; 4(4):693-703. PubMed ID: 32472647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Refining the ITBCC tumor budding scoring system with a "zero-budding" category in colorectal cancer.
    Zlobec I; Bächli M; Galuppini F; Berger MD; Dawson HE; Nagtegaal ID; Lugli A
    Virchows Arch; 2021 Dec; 479(6):1085-1090. PubMed ID: 33843013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-grade intratumoral tumor budding is a predictor for lymphovascular invasion and adverse outcome in stage II colorectal cancer.
    Marx AH; Mickler C; Sauter G; Simon R; Terracciano LM; Izbicki JR; Clauditz TS
    Int J Colorectal Dis; 2020 Feb; 35(2):259-268. PubMed ID: 31838579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Traditional Serrated Pathway-associated Colorectal Carcinoma: Morphologic Reappraisal of Serrated Morphology, Tumor Budding, and Identification of Frequent PTEN Alterations.
    Tsai JH; Jeng YM; Yuan CT; Lin YL; Cheng ML; Liau JY
    Am J Surg Pathol; 2019 Aug; 43(8):1042-1051. PubMed ID: 31094930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of CDX2 in colorectal cancer is associated with histopathologic subtypes and microsatellite instability but is prognostically inferior to hematoxylin-eosin-based morphologic parameters from the WHO classification.
    Konukiewitz B; Schmitt M; Silva M; Pohl J; Lang C; Steiger K; Halfter K; Engel J; Schlitter AM; Boxberg M; Pfarr N; Wilhelm D; Foersch S; Tschurtschenthaler M; Weichert W; Jesinghaus M
    Br J Cancer; 2021 Dec; 125(12):1632-1646. PubMed ID: 34616012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A novel histological typing and grading-scale system of colorectal cancer].
    Yang J; Guo R; Kang A; Chen X; Su B; Huang X; Jin Y; Li Z
    Nan Fang Yi Ke Da Xue Xue Bao; 2014 Feb; 34(2):169-73. PubMed ID: 24589590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor Grade Is Prognostically Relevant Among Mismatch Repair Deficient Colorectal Carcinomas.
    Johncilla M; Chen Z; Sweeney J; Yantiss RK
    Am J Surg Pathol; 2018 Dec; 42(12):1686-1692. PubMed ID: 30179899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular Dissociation Grading Based on the Parameters Tumor Budding and Cell Nest Size in Pretherapeutic Biopsy Specimens Allows for Prognostic Patient Stratification in Esophageal Squamous Cell Carcinoma Independent From Clinical Staging.
    Jesinghaus M; Brühl F; Steiger K; Klare P; Reiser M; Scheiter A; Konukiewitz B; Kuhn P; Münch S; Quante M; Schmid RM; Wilhelm D; Feith M; Friess H; Combs SE; Saur D; Boxberg M; Weichert W
    Am J Surg Pathol; 2019 May; 43(5):618-627. PubMed ID: 30807302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship between tumor budding and survival in colorectal carcinomas.
    Ozer SP; Barut SG; Ozer B; Catal O; Sit M
    Rev Assoc Med Bras (1992); 2019 Dec; 65(12):1442-1447. PubMed ID: 31994623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Should the grading of colorectal adenocarcinoma include microsatellite instability status?
    Rosty C; Williamson EJ; Clendenning M; Walters RJ; Win AK; Jenkins MA; Hopper JL; Winship IM; Southey MC; Giles GG; English DR; Buchanan DD
    Hum Pathol; 2014 Oct; 45(10):2077-84. PubMed ID: 25149551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor budding is an independent predictor of outcome in AJCC/UICC stage II colorectal cancer.
    Betge J; Kornprat P; Pollheimer MJ; Lindtner RA; Schlemmer A; Rehak P; Vieth M; Langner C
    Ann Surg Oncol; 2012 Nov; 19(12):3706-12. PubMed ID: 22669453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor Budding in Colorectal Carcinoma: Confirmation of Prognostic Significance and Histologic Cutoff in a Population-based Cohort.
    Graham RP; Vierkant RA; Tillmans LS; Wang AH; Laird PW; Weisenberger DJ; Lynch CF; French AJ; Slager SL; Raissian Y; Garcia JJ; Kerr SE; Lee HE; Thibodeau SN; Cerhan JR; Limburg PJ; Smyrk TC
    Am J Surg Pathol; 2015 Oct; 39(10):1340-6. PubMed ID: 26200097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathologic features of gastric cancer with synchronous and metachronous colorectal cancer in Korea: are microsatellite instability and p53 overexpression useful markers for predicting colorectal cancer in gastric cancer patients?
    Kim HJ; Kim N; Choi YJ; Yoon H; Shin CM; Park YS; Lee HS; Ahn SH; Park do J; Kim HH; Son IT; Kang SB; Lee DH
    Gastric Cancer; 2016 Jul; 19(3):798-807. PubMed ID: 26445944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor budding and poorly-differentiated cluster in prognostication in Stage II colon cancer.
    Lee VWK; Chan KF
    Pathol Res Pract; 2018 Mar; 214(3):402-407. PubMed ID: 29487008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor budding in colorectal carcinoma: An institutional interobserver reliability and prognostic study of colorectal adenocarcinoma cases.
    Hacking S; Angert M; Jin C; Kline M; Gupta N; Cho M; Thomas R; Lee L; Chavarria H; Nasim M
    Ann Diagn Pathol; 2019 Dec; 43():151420. PubMed ID: 31731034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.